BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 20444971)

  • 21. [Evaluation of the performance of the MicroScan Pos Breakpoint Combo Panel Type 28 for susceptibility testing of Staphylococcus aureus: low-range minimum inhibitory concentration of vancomycin, cefoxitin screening, and inducible clindamycin resistance detection].
    Ji M; Lee M; Noh S; Kim MN
    Korean J Lab Med; 2010 Dec; 30(6):637-46. PubMed ID: 21157151
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In vitro activity of retapamulin against Staphylococcus aureus isolates resistant to fusidic acid and mupirocin.
    Woodford N; Afzal-Shah M; Warner M; Livermore DM
    J Antimicrob Chemother; 2008 Oct; 62(4):766-8. PubMed ID: 18567573
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prevalence of mupirocin resistance in clinical isolates of Staphylococcus aureus and Staphylococcus epidermidis: results of the Antimicrobial Resistance Surveillance Study of the Paul-Ehrlich-Society for Chemotherapy, 2001.
    Kresken M; Hafner D; Schmitz FJ; Wichelhaus TA;
    Int J Antimicrob Agents; 2004 Jun; 23(6):577-81. PubMed ID: 15194128
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mupirocin resistance screening of methicillin-resistant Staphylococcus aureus isolates at Madigan Army Medical Center.
    Perkins D; Hogue JS; Fairchok M; Braun L; Viscount HB
    Mil Med; 2008 Jun; 173(6):604-8. PubMed ID: 18595427
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mupirocin-resistant
    Shittu AO; Kaba M; Abdulgader SM; Ajao YO; Abiola MO; Olatimehin AO
    Antimicrob Resist Infect Control; 2018; 7():101. PubMed ID: 30147868
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Heterogeneity of antimicrobial susceptibility testing results for sulfamethoxazole/trimethoprim obtained from clinical equine Staphylococcus aureus isolates using different methods.
    Scholtzek AD; Hanke D; Eichhorn I; Walther B; Lübke-Becker A; van Duijkeren E; Köck R; Schwarz S; Feßler AT
    Vet Microbiol; 2020 Mar; 242():108600. PubMed ID: 32122605
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clonal dissemination and mupA gene polymorphism of mupirocin-resistant Staphylococcus aureus isolates from long-term-care facilities in South Korea.
    Yoo JI; Shin ES; Cha JO; Lee JK; Jung YH; Lee KM; Kim BS; Lee YS
    Antimicrob Agents Chemother; 2006 Jan; 50(1):365-7. PubMed ID: 16377713
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Chlorhexidine and mupirocin susceptibilities in methicillin-resistant Staphylococcus aureus isolates from bacteraemia and nasal colonisation.
    Muñoz-Gallego I; Infiesta L; Viedma E; Perez-Montarelo D; Chaves F
    J Glob Antimicrob Resist; 2016 Mar; 4():65-69. PubMed ID: 27436397
    [TBL] [Abstract][Full Text] [Related]  

  • 29. New quadriplex PCR assay for detection of methicillin and mupirocin resistance and simultaneous discrimination of Staphylococcus aureus from coagulase-negative staphylococci.
    Zhang K; Sparling J; Chow BL; Elsayed S; Hussain Z; Church DL; Gregson DB; Louie T; Conly JM
    J Clin Microbiol; 2004 Nov; 42(11):4947-55. PubMed ID: 15528678
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Testing for induction of clindamycin resistance in erythromycin-resistant isolates of Staphylococcus aureus.
    Steward CD; Raney PM; Morrell AK; Williams PP; McDougal LK; Jevitt L; McGowan JE; Tenover FC
    J Clin Microbiol; 2005 Apr; 43(4):1716-21. PubMed ID: 15814990
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Improvement of mupirocin E-test for susceptibility testing of Staphylococcus aureus.
    Mondino PJJ; Netto Dos Santos KR; do Carmo de Freire Bastos M; Giambiagi-deMarval M
    J Med Microbiol; 2003 May; 52(Pt 5):385-387. PubMed ID: 12721313
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Proposed MIC and disk diffusion microbiological cutoffs and spectrum of activity of retapamulin, a novel topical antimicrobial agent.
    Traczewski MM; Brown SD
    Antimicrob Agents Chemother; 2008 Nov; 52(11):3863-7. PubMed ID: 18725451
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of Oxacillin and Cefoxitin Disk Diffusion and Microbroth Dilution Methods for Detecting
    Naccache SN; Callan K; Burnham CA; Wallace MA; Westblade LF; Dien Bard J;
    J Clin Microbiol; 2019 Dec; 57(12):. PubMed ID: 31462553
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Emergence of a Staphylococcus aureus Clone Resistant to Mupirocin and Fusidic Acid Carrying Exotoxin Genes and Causing Mainly Skin Infections.
    Doudoulakakis A; Spiliopoulou I; Spyridis N; Giormezis N; Kopsidas J; Militsopoulou M; Lebessi E; Tsolia M
    J Clin Microbiol; 2017 Aug; 55(8):2529-2537. PubMed ID: 28592549
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prevalence of clinical meticillin-resistant Staphylococcus aureus (MRSA) with high-level mupirocin resistance in Shanghai and Wenzhou, China.
    Liu QZ; Wu Q; Zhang YB; Liu MN; Hu FP; Xu XG; Zhu DM; Ni YX
    Int J Antimicrob Agents; 2010 Feb; 35(2):114-8. PubMed ID: 19939636
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Clinical Utility of Analysis High Resolution Melting Curve Assay for Simultaneous Identification of Methicillin and Mupirocin Resistant in Coagulase-Negative Staphylococci.
    Dehbashi S; Tahmasebi H; Arabestani MR
    Clin Lab; 2019 Oct; 65(10):. PubMed ID: 31625356
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of three techniques for detection of low-level methicillin-resistant Staphylococcus aureus (MRSA): a disk diffusion method with cefoxitin and moxalactam, the Vitek 2 system, and the MRSA-screen latex agglutination test.
    Felten A; Grandry B; Lagrange PH; Casin I
    J Clin Microbiol; 2002 Aug; 40(8):2766-71. PubMed ID: 12149327
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Genetic analysis of methicillin-resistant Staphylococcus aureus expressing high- and low-level mupirocin resistance.
    Udo EE; Jacob LE; Mathew B
    J Med Microbiol; 2001 Oct; 50(10):909-915. PubMed ID: 11599741
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of new Vitek 2 card and disk diffusion method for determining susceptibility of Staphylococcus aureus to oxacillin.
    Roisin S; Nonhoff C; Denis O; Struelens MJ
    J Clin Microbiol; 2008 Aug; 46(8):2525-8. PubMed ID: 18550733
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Results of disk diffusion testing with cefoxitin correlate with presence of mecA in Staphylococcus spp.
    Swenson JM; Tenover FC;
    J Clin Microbiol; 2005 Aug; 43(8):3818-23. PubMed ID: 16081917
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.